0001493152-17-003302.txt : 20170331
0001493152-17-003302.hdr.sgml : 20170331
20170331195916
ACCESSION NUMBER: 0001493152-17-003302
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161231
FILED AS OF DATE: 20170331
DATE AS OF CHANGE: 20170331
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VBI Vaccines Inc/BC
CENTRAL INDEX KEY: 0000764195
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 222 THIRD STREET
STREET 2: SUITE 2241
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-830-3031
MAIL ADDRESS:
STREET 1: 222 THIRD STREET
STREET 2: SUITE 2241
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: SciVac Therapeutics Inc.
DATE OF NAME CHANGE: 20150717
FORMER COMPANY:
FORMER CONFORMED NAME: LEVON RESOURCES LTD.
DATE OF NAME CHANGE: 20100910
FORMER COMPANY:
FORMER CONFORMED NAME: LEVON RESOURCES LTD
DATE OF NAME CHANGE: 19850305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Buckley T. Adam
CENTRAL INDEX KEY: 0001615926
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37769
FILM NUMBER: 17731970
MAIL ADDRESS:
STREET 1: C/O VBI VACCINES INC.,
STREET 2: 222 THIRD STREET, STE 2241
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
3
1
form3.xml
X0206
3
2016-12-31
0
0000764195
VBI Vaccines Inc/BC
VBIV
0001615926
Buckley T. Adam
C/O VBI VACCINES INC.
222 THIRD STREET, STE 2241
CAMBRIDGE
MA
02142
0
1
0
0
VP, Business Development
Common Shares, no par value per share
39376
D
Restricted Stock Units (RSUs)
0.00
2026-06-14
Common Shares
14062
D
Option (Right to Buy Common Shares)
2.50
2018-03-18
Common Shares
1946
D
Option (Right to Buy Common Shares)
5.06
2019-01-21
Common Shares
3735
D
Option (Right to Buy Common Shares)
2.50
2022-03-29
Common Shares
5357
D
Option (Right to Buy Common Shares)
2.50
2022-04-02
Common Shares
3826
D
Option (Right to Buy Common Shares)
4.13
2024-07-25
Common Shares
71224
D
Option (Right to Buy Common Shares)
4.93
2025-07-30
Common Shares
39015
D
Each RSU represents a contingent right to receive 1 common share of the Issuer upon settlement.
The RSUs vest 1/3 per year over 3 years, beginning on June 22, 2017, subject to continued service through each vesting date.
The option is fully vested.
The option vests 1/48th of the total shares monthly following the grant date of July 25, 2014, subject to continued service through each vesting date.
The option vests 1/48th of the total shares monthly following the grant date of July 30, 2015, subject to continued service through each vesting date.
/s/ T.Adam Buckley
2017-03-31